These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25850834)

  • 1. Feasibility of modified short-course radiotherapy combined with a chemoradiosensitizer for T3 rectal cancer.
    Beppu N; Matsubara N; Kakuno A; Doi H; Kamikonya N; Yamanaka N; Yanagi H; Tomita N
    Dis Colon Rectum; 2015 May; 58(5):479-87. PubMed ID: 25850834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
    Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO
    Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma.
    Sadahiro S; Suzuki T; Tanaka A; Okada K; Kamijo A; Murayama C; Akiba T; Nakayama Y
    Oncology; 2011; 81(5-6):306-11. PubMed ID: 22156392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
    Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
    Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative incidence of permanent stoma after sphincter preserving low anterior resection of mid and low rectal cancer.
    Dinnewitzer A; Jäger T; Nawara C; Buchner S; Wolfgang H; Öfner D
    Dis Colon Rectum; 2013 Oct; 56(10):1134-42. PubMed ID: 24022530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robotic coloanal anastomosis with or without intersphincteric resection for low rectal cancer: starting with the perianal approach followed by robotic procedure.
    Kang J; Hur H; Min BS; Lee KY; Kim NK
    Ann Surg Oncol; 2012 Jan; 19(1):154-5. PubMed ID: 21822556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative chemoradiotherapy with S-1 for advanced low rectal cancer].
    Kitani K; Okajima K; Sato K; Isono S; Kimura H; Ikeda M; Inoue K; Iwama M; Tsujie M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ota Y; Inoue M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2122-4. PubMed ID: 22202303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative radiotherapy combined with S-1 for advanced lower rectal cancer: phase I trial.
    Morimoto S; Shimada M; Kurita N; Sato H; Iwata T; Nishioka M; Yoshikawa K; Miyatani T; Kashihara H; Takasu C; Ikushima H
    Hepatogastroenterology; 2012; 59(117):1428-32. PubMed ID: 22155856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
    Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
    Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course radiotherapy with delayed surgery versus conventional chemoradiotherapy: A comparison of the short- and long-term outcomes in patients with T3 rectal cancer.
    Beppu N; Matsubara N; Noda M; Yamano T; Kakuno A; Doi H; Kamikonya N; Kimura F; Yamanaka N; Yanagi H; Tomita N
    Surgery; 2015 Jul; 158(1):225-35. PubMed ID: 25900036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
    Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
    Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery.
    Kim CW; Kim JH; Yu CS; Shin US; Park JS; Jung KY; Kim TW; Yoon SN; Lim SB; Kim JC
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):156-63. PubMed ID: 20106604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical and functional results of intersphincteric resection for lower rectal cancer.
    Koyama M; Murata A; Sakamoto Y; Morohashi H; Takahashi S; Yoshida E; Hakamada K
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S422-8. PubMed ID: 24562938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I trial of preoperative chemoradiation therapy with S-1 for low rectal cancer.
    Funahashi K; Koike J; Shiokawa H; Ushigome M; Shimada H; Kaneko H; Terahara A
    Hepatogastroenterology; 2014; 61(129):99-104. PubMed ID: 24895802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
    Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
    Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of pathological complete response of advanced rectal cancer to preoperative chemoradiotherapy using S-1.
    Tanishima H; Horiuchi T; Tamagawa K; Tsujimoto T; Miyagawa Y; Ishida K; Uemura R; Hama T; Sakaguchi S; Shono Y; Tsubakihara H; Tabuse K
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1397-400. PubMed ID: 20647736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge.
    Kim DW; Lim SB; Kim DY; Kim TH; Jung KH; Kim DH; Chang HJ; Sohn DK; Hong CW; Choi HS; Jeong SY; Park JG
    Eur J Surg Oncol; 2006 Mar; 32(2):162-7. PubMed ID: 16289718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transabdominal transanal resection of distal rectal cancer after high dose preoperative radiotherapy: a Chinese experience in preserving sphincter function.
    Zhou JN; Wang DZ; Huang XE; Xu FP; Shang JQ; Gu RM
    Isr Med Assoc J; 2006 Oct; 8(10):675-8. PubMed ID: 17125111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes after intersphincteric resection for low-lying rectal cancer.
    Saito N; Ito M; Kobayashi A; Nishizawa Y; Kojima M; Nishizawa Y; Sugito M
    Ann Surg Oncol; 2014 Oct; 21(11):3608-15. PubMed ID: 24923221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.